Claim by researcher of injecting iPS cells into heart failure patients found to be fraudulent

October 15, 2012 by Bob Yirka weblog

(Medical Xpress)—Shortly after it was announced that Japanese researcher Shinya Yamanaka had won the Nobel Prize in Physiology or Medicine for his work in seeking alternatives to embryonic cells for use in stem cell research, fellow Japanese researcher Hisashi Moriguchi claimed that he and a team had injected iPS cells into the hearts of six human patients at Harvard Medical Center. Now it appears that such claims were false. In a recent press conference, Moriguchi changed his story and insisted that the procedure had taken place at a Boston hospital, and that just one patient was involved, not six – the other five were still in the planning stages.

In changing his story, Moriguchi also stated that he had lied in his initial account. That version was published by Japan's biggest newspaper Yomiuri Shimbun which also stated that Moriguchi had received permission for the procedure from Harvard Medical School's Institutional Review Board (IRB). The IRB has stated that no such permission was given, nor was any such procedure performed.

The revelations about Moriguchi have caused reporters and the editors of to investigate further his previous research and publications. In so doing they have found discrepancies in published reports of claims he's made, papers that list his name as author, and affiliations he has claimed as part of his work. In one instance, he was quoted by the newspaper Nihon Keizai Shimbun as stating that he had used iPS to treat Hepatitis patients. In another instance, officials from Massachusetts General Hospital (MGH) reported that one of its staff members was listed in the first reference as an author of a paper submitted by Moriguchi. No evidence has been found that Moriguchi conducted any iPS treatment of Hepatitis patients, and the staff member at MGH says he never worked with Moriguchi. In addition, officials from Harvard have gone on record as saying that Moriguchi has not worked at any of their affiliated hospitals since a brief stint as a visiting fellow at MGH in 2000.

Moriguchi also claimed in a short correspondence printed in Hepatology in 2010, that he had devised a new way to create iPS cells, using just two chemicals, work that has not been verified and Nature's news blog has pointed out that images Moriguchi used in publications seem "remarkably similar" to images on the Advanced Fertility Center of Chicago's web site.

In light of mounting evidence suggesting Moriguchi has been engaging in fraudulent activities, Yomiuri Shimbun printed a front page apology over its announcement heralding Moriguchi's achievement and at the end of his latest press conference, Moriguchi conceded that his career is likely over.

Explore further: Stem cells improve damaged spines in mice

Related Stories

Stem cells improve damaged spines in mice

February 5, 2009

A team of researchers at Keio University has succeeded in improving spinal cord damage in mice by transplanting into them neural stem cells produced with human induced pluripotent stem (iPS) cells, they said.

The future of stem cell research

December 8, 2010

Perhaps no single scientist has had a greater impact on stem cell research than Dr. Shinya Yamanaka. While most of his colleagues were looking for ways to grow human embryonic stem cells into replacement tissues for treating ...

Japan team create liver from stem cells: report

June 8, 2012

Japanese researchers have created a functioning human liver from stemcells, a report said Friday, raising hopes for the manufacture of artificial organs for those in need of transplants.

Recommended for you

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...


Adjust slider to filter visible comments by rank

Display comments: newest first

3 / 5 (2) Oct 15, 2012
" the end of his latest press conference, Moriguchi conceded that his career is likely over." Maybe the first honest thing he said.
This type of lying is becoming more prevalent in science publishing. The reason is that the people doing the false reports are dishonest people.
5 / 5 (1) Oct 15, 2012
1. Publish or perish puts a lot of pressure on researchers.

2. As the bubble of scientific knowledge expands, individual scientists are becoming increasingly detached from what that bubble contains, and hence are increasingly incapable of policing others.

3. The reduction in policing capacity provides an opportunity for some to cheat.
2.3 / 5 (3) Oct 15, 2012
Dear people with heart disease.
I am sorry but I may have mislead you a touch about how far along my research was. In fact, I may have lied my a** off. I hope I didn't get your hopes raised too high, which I almost certainly did. No hard feelings.
3 / 5 (2) Oct 15, 2012
What does Shinya Yamanaka have to do with this story other than that he's Japanese? If he hasn't co-authored a paper with Moriguchi, or at the very least hasn't worked in the same lab, he shouldn't have his name besmirched here.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.